L-Ornithine L-Aspartate

An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.

Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding

L-ornithine L-aspartate in Overt Hepatic Encephalopathy

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy